155 related articles for article (PubMed ID: 16055813)
1. Rational pharmacotherapy in early psychosis.
Remington G
Br J Psychiatry Suppl; 2005 Aug; 48():s77-84. PubMed ID: 16055813
[TBL] [Abstract][Full Text] [Related]
2. Clinical guideline recommendations for antipsychotic long-acting injections.
Kane JM; Garcia-Ribera C
Br J Psychiatry Suppl; 2009 Nov; 52():S63-7. PubMed ID: 19880920
[TBL] [Abstract][Full Text] [Related]
3. Pharmacotherapy of first episode psychosis in Estonia: comparison with national and international treatment guidelines.
Lass J; Männik A; Bell JS
J Clin Pharm Ther; 2008 Apr; 33(2):165-73. PubMed ID: 18315782
[TBL] [Abstract][Full Text] [Related]
4. First-episode schizophrenia. Early intervention and medication discontinuation in the context of course and treatment.
Wyatt RJ; Damiani LM; Henter ID
Br J Psychiatry Suppl; 1998; 172(33):77-83. PubMed ID: 9764131
[TBL] [Abstract][Full Text] [Related]
5. Oral versus injectable antipsychotic treatment in early psychosis: post hoc comparison of two studies.
Emsley R; Oosthuizen P; Koen L; Niehaus DJ; Medori R; Rabinowitz J
Clin Ther; 2008 Dec; 30(12):2378-86. PubMed ID: 19167596
[TBL] [Abstract][Full Text] [Related]
6. Hippocampal and amygdala volumes according to psychosis stage and diagnosis: a magnetic resonance imaging study of chronic schizophrenia, first-episode psychosis, and ultra-high-risk individuals.
Velakoulis D; Wood SJ; Wong MT; McGorry PD; Yung A; Phillips L; Smith D; Brewer W; Proffitt T; Desmond P; Pantelis C
Arch Gen Psychiatry; 2006 Feb; 63(2):139-49. PubMed ID: 16461856
[TBL] [Abstract][Full Text] [Related]
7. Who needs antipsychotic medication in the earliest stages of psychosis? A reconsideration of benefits, risks, neurobiology and ethics in the era of early intervention.
Francey SM; Nelson B; Thompson A; Parker AG; Kerr M; Macneil C; Fraser R; Hughes F; Crisp K; Harrigan S; Wood SJ; Berk M; McGorry PD
Schizophr Res; 2010 Jun; 119(1-3):1-10. PubMed ID: 20347270
[TBL] [Abstract][Full Text] [Related]
8. Assessing clinicians' management of first episode schizophrenia using clinical case vignettes.
Huffman JC; Freudenreich O; Romeo S; Baer L; Sutton-Skinner K; Petersen T; Fromson JA; Birnbaum RJ
Early Interv Psychiatry; 2010 Feb; 4(1):31-8. PubMed ID: 20199478
[TBL] [Abstract][Full Text] [Related]
9. Neuroprotection: a new strategy in the treatment of schizophrenia. Treatment of first-episode psychosis.
Buckley PF
CNS Spectr; 2007 Oct; 12(10 Suppl 18):7-10. PubMed ID: 19322958
[No Abstract] [Full Text] [Related]
10. Understanding and treating "first-episode" schizophrenia.
Weiden PJ; Buckley PF; Grody M
Psychiatr Clin North Am; 2007 Sep; 30(3):481-510. PubMed ID: 17720033
[TBL] [Abstract][Full Text] [Related]
11. Naturalistic pharmacotherapy of acute episodes of schizophrenic disorders in comparison to treatment guidelines.
Stein M; Dietrich DE; Agelink MW; Becker W; Chrysanthou C; Driessen M; Kruse G; Machleidt W; Reker T; Schneider U; Schulze Mönking H; Emrich HM; Arolt V; Rothermundt M
Pharmacopsychiatry; 2012 Jul; 45(5):189-95. PubMed ID: 22456956
[TBL] [Abstract][Full Text] [Related]
12. Serotonin and dopamine interactions in psychosis prevention.
Richtand NM; McNamara RK
Prog Brain Res; 2008; 172():141-53. PubMed ID: 18772031
[TBL] [Abstract][Full Text] [Related]
13. First-episode psychosis: an epidemiological survey comparing psychotic depression with schizophrenia.
Crebbin K; Mitford E; Paxton R; Turkington D
J Affect Disord; 2008 Jan; 105(1-3):117-24. PubMed ID: 17574683
[TBL] [Abstract][Full Text] [Related]
14. Empirical evidence for psychopharmacologic treatment in early-onset psychosis and schizophrenia.
Maloney AE; Yakutis LJ; Frazier JA
Child Adolesc Psychiatr Clin N Am; 2012 Oct; 21(4):885-909. PubMed ID: 23040906
[TBL] [Abstract][Full Text] [Related]
15. Analysis of clinical characteristics and antipsychotic medication prescribing practices of first-episode schizophrenia in Israel: a naturalistic prospective study.
Strous RD; Bar F; Keret N; Lapidus R; Kosov N; Chelben J; Kotler M
Isr J Psychiatry Relat Sci; 2006; 43(1):2-9. PubMed ID: 16910378
[TBL] [Abstract][Full Text] [Related]
16. Examining the effectiveness of antipsychotic medication in first-episode psychosis.
Taylor M; Cavanagh J; Hodgson R; Tiihonen J
J Psychopharmacol; 2012 May; 26(5 Suppl):27-32. PubMed ID: 22337711
[TBL] [Abstract][Full Text] [Related]
17. Duration of untreated psychosis and it's effect on the symptomatic recovery in schizophrenia - preliminary results.
Novak Sarotar B; Pesek MB; Agius M; Kocmur M
Neuro Endocrinol Lett; 2008 Dec; 29(6):990-4. PubMed ID: 19112411
[TBL] [Abstract][Full Text] [Related]
18. Associations between adherence to guidelines for antipsychotic dose and health status, side effects, and patient care experiences.
Dickey B; Normand SL; Eisen S; Hermann R; Cleary P; Cortés D; Ware N
Med Care; 2006 Sep; 44(9):827-34. PubMed ID: 16932134
[TBL] [Abstract][Full Text] [Related]
19. Cannabis abuse is associated with decision-making impairment among first-episode patients with schizophrenia-spectrum psychosis.
Mata I; Rodríguez-Sánchez JM; Pelayo-Terán JM; Pérez-Iglesias R; González-Blanch C; Ramírez-Bonilla M; Martínez-García O; Vázquez-Barquero JL; Crespo-Facorro B
Psychol Med; 2008 Sep; 38(9):1257-66. PubMed ID: 18005495
[TBL] [Abstract][Full Text] [Related]
20. Grey matter abnormalities in Brazilians with first-episode psychosis.
Schaufelberger MS; Duran FL; Lappin JM; Scazufca M; Amaro E; Leite CC; de Castro CC; Murray RM; McGuire PK; Menezes PR; Busatto GF
Br J Psychiatry Suppl; 2007 Dec; 51():s117-22. PubMed ID: 18055927
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
